Scilex Holding Company (SCLX) Stock Analysis

Scilex Holding Company (SCLX) is a publicly traded company in the HEALTHCARE sector. It trades at $7.40, carries a market capitalization of $56.19M. This page summarizes the public market data, fundamentals, and frequently asked questions for SCLX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NASDAQ

Key Metrics

• Price: $7.40
• Market Cap: $56.19M
• EPS: $-40.50
• 52-Week High: $34.27
• 52-Week Low: $4.20

Market Sentiment

Scilex Holding Company currently has a Bullish sentiment score of 0.32.

About Scilex Holding Company

Scilex Holding Company is a biopharmaceutical firm based in Palo Alto, California, dedicated to innovating and commercializing non-opioid therapeutics specifically aimed at addressing both acute and chronic pain management. With a commitment to improving patient outcomes while minimizing reliance on opioid medications, Scilex is at the forefront of developing alternative solutions that cater to the growing need for effective pain relief options. Through its cutting-edge research and developme...

GNG Research Analysis

GNG Research scores Scilex Holding Company (SCLX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SCLX.

Frequently Asked Questions

Does SCLX pay dividends?

Scilex Holding Company (SCLX) does not currently pay a regular dividend.

What is SCLX's market cap?

Scilex Holding Company (SCLX) has a market capitalization of $56.19M with a current stock price of $7.40.